​

Humana (HUM) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HUM Stock Forecast

Humana (HUM) stock forecast, based on 43 Wall Street analysts, predicts a 12-month average price target of $235.00, with a high of $345.00 and a low of $146.00. This represents a 37.47% increase from the last price of $170.95.

$100 $180 $260 $340 $420 $500 High: $345 Avg: $235 Low: $146 Last Closed Price: $170.95

HUM Stock Rating

Humana stock's rating consensus is Hold, based on 43 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (32.56%), 27 Hold (62.79%), 2 Sell (4.65%), and 0 Strong Sell (0.00%).

Hold
Total 43 2 27 14 0 Strong Sell Sell Hold Buy Strong Buy

HUM Price Target Upside V Benchmarks

TypeNameUpside
StockHumana37.47%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks29.16%

Price Target Trends

1M3M12M
# Anlaysts31328
Avg Price Target$195.33$222.23$260.86
Last Closing Price$170.95$170.95$170.95
Upside/Downside14.26%30.00%52.59%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2626172-27
Feb, 2636172-28
Jan, 2637161-27
Dec, 2536171-27
Nov, 2526181-27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 18, 2026Wells Fargo$206.00$184.9911.36%20.50%
Feb 17, 2026Truist Financial$200.00$185.367.90%16.99%
Feb 13, 2026George HillDeutsche Bank$180.00$182.87-1.57%5.29%
Feb 12, 2026UBS$195.00$176.2410.64%14.07%
Feb 12, 2026Oppenheimer$250.00$173.8143.84%46.24%
Feb 12, 2026Morgan Stanley$146.00$175.40-16.76%-14.59%
Feb 12, 2026Guggenheim$252.00$175.4043.67%47.41%
Feb 12, 2026Ben HendrixRBC Capital$189.00$175.407.75%10.56%
Feb 02, 2026Morgan Stanley$174.00$195.20-10.86%1.78%
Jan 07, 2026Wells Fargo$290.00$279.843.63%69.64%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 25, 2026UBSNeutralNeutralhold
Feb 13, 2026Deutsche BankHoldHoldhold
Feb 12, 2026Cantor FitzgeraldNeutralNeutralhold
Feb 12, 2026RBC CapitalOutperformSector Performdowngrade
Feb 02, 2026Morgan StanleyUnderperformUnderweightdowngrade
Jan 07, 2026Wells FargoOverweightCautiousdowngrade
Jan 06, 2026BernsteinOutperformOutperformhold
Jan 05, 2026BarclaysUnderperformerUnderperformerhold
Dec 18, 2025Morgan StanleyUnderperformUnderperformhold
Dec 12, 2025KeyBancSector WeightSector Weighthold

Financial Forecast

EPS Forecast

$5 $13 $21 $29 $37 $45 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$22.79$22.20$20.09$10.01$9.87---
Avg Forecast$20.54$25.06$27.17$16.15$16.73$14.11$23.92$38.29
High Forecast$21.49$26.44$27.47$16.29$17.53$16.80$30.54$41.24
Low Forecast$20.04$24.16$25.31$15.89$16.19$11.18$18.59$36.48
Surprise %10.95%-11.41%-26.06%-38.02%-41.00%---

Revenue Forecast

$80B $93B $106B $119B $132B $145B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$83.65B$92.92B$106.44B$117.81B$129.66B---
Avg Forecast$83.07B$92.96B$104.82B$117.02B$119.65B$120.24B$127.73B$134.70B
High Forecast$86.04B$96.92B$105.19B$117.38B$125.04B$120.47B$128.10B$142.69B
Low Forecast$81.54B$90.40B$104.65B$116.54B$116.84B$120.01B$127.35B$129.81B
Surprise %0.69%-0.04%1.55%0.68%8.37%---

Net Income Forecast

$1B $2B $3B $4B $5B $6B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.93B$2.81B$2.49B$1.21B$1.19B---
Avg Forecast$2.79B$2.95B$2.49B$2.00B$2.10B$1.59B$2.40B$4.76B
High Forecast$3.35B$3.55B$2.99B$2.03B$2.18B$2.09B$3.80B$5.13B
Low Forecast$2.22B$2.36B$1.99B$1.98B$2.01B$1.39B$2.31B$4.54B
Surprise %5.24%-4.94%--39.70%-43.38%---

HUM Forecast FAQ

Is Humana stock a buy?

Humana stock has a consensus rating of Hold, based on 43 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 27 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Humana is a neutral investment for most analysts.

What is Humana's price target?

Humana's price target, set by 43 Wall Street analysts, averages $235 over the next 12 months. The price target range spans from $146 at the low end to $345 at the high end, suggesting a potential 37.47% change from the previous closing price of $170.95.

How does Humana stock forecast compare to its benchmarks?

Humana's stock forecast shows a 37.47% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare plans stocks industry (29.16%).

What is the breakdown of analyst ratings for Humana over the past three months?

  • March 2026: 7.41% Strong Buy, 22.22% Buy, 62.96% Hold, 7.41% Sell, 0% Strong Sell.
  • February 2026: 10.71% Strong Buy, 21.43% Buy, 60.71% Hold, 7.14% Sell, 0% Strong Sell.
  • January 2026: 11.11% Strong Buy, 25.93% Buy, 59.26% Hold, 3.70% Sell, 0% Strong Sell.

What is Humana’s EPS forecast?

Humana's average annual EPS forecast for its fiscal year ending in December 2026 is $14.11, marking a 42.96% increase from the reported $9.87 in 2025. Estimates for the following years are $23.92 in 2027, and $38.29 in 2028.

What is Humana’s revenue forecast?

Humana's average annual revenue forecast for its fiscal year ending in December 2026 is $120.24B, reflecting a -7.27% decrease from the reported $129.66B in 2025. The forecast for 2027 is $127.73B, and $134.7B for 2028.

What is Humana’s net income forecast?

Humana's net income forecast for the fiscal year ending in December 2026 stands at $1.59B, representing an 33.49% increase from the reported $1.19B in 2025. Projections indicate $2.4B in 2027, and $4.76B in 2028.